Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Kaye

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|January 11, 2021
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile applicationDavid Richardson, Lin Zhan, Reshma Mahtani, et al.
Pharmacotherapy|April 4, 2017
Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic BiasJames A Kaye, Andrea V Margulis, Joan Fortuny, et al.
Future Oncology (London, England)|June 10, 2020
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countriesZdravko P Vassilev, Montse Soriano Gabarró, James A Kaye, et al.
Sarcoma|October 10, 2018
Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and FranceDaniel S Mytelka, Saurabh P Nagar, Yulia D'yachkova, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2023
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claimsDjeneba Audrey Djibo, Andrea V Margulis, Cheryl N McMahill-Walraven, et al.
Pharmacotherapy|May 14, 2003
Validity of the general practice research databaseSusan S Jick, James A Kaye, Catherine Vasilakis-Scaramozza, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2014
Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature reviewAnn Colosia, Annete Njue, Peter C Trask, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2014
Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature reviewAnnete Njue, Ann Colosia, Peter C Trask, et al.
Current Medical Research and Opinion|May 8, 2019
Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancerRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Basic & Clinical Pharmacology & Toxicology|January 19, 2018
Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort StudyJesper Hallas, Andrea V Margulis, Anton Pottegård, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|January 11, 2021
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile applicationDavid Richardson, Lin Zhan, Reshma Mahtani, et al.
Pharmacotherapy|April 4, 2017
Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic BiasJames A Kaye, Andrea V Margulis, Joan Fortuny, et al.
Future Oncology (London, England)|June 10, 2020
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countriesZdravko P Vassilev, Montse Soriano Gabarró, James A Kaye, et al.
Sarcoma|October 10, 2018
Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and FranceDaniel S Mytelka, Saurabh P Nagar, Yulia D'yachkova, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2023
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claimsDjeneba Audrey Djibo, Andrea V Margulis, Cheryl N McMahill-Walraven, et al.
Pharmacotherapy|May 14, 2003
Validity of the general practice research databaseSusan S Jick, James A Kaye, Catherine Vasilakis-Scaramozza, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2014
Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature reviewAnn Colosia, Annete Njue, Peter C Trask, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2014
Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature reviewAnnete Njue, Ann Colosia, Peter C Trask, et al.
Current Medical Research and Opinion|May 8, 2019
Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancerRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Basic & Clinical Pharmacology & Toxicology|January 19, 2018
Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort StudyJesper Hallas, Andrea V Margulis, Anton Pottegård, et al.
Pageof 11